{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:26:13Z","timestamp":1790832373610,"version":"4.1.0"},"reference-count":31,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T00:00:00Z","timestamp":1578614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Calcium electroporation (Ca-EP) is a new anticancer treatment providing similar features to electrochemotherapy (ECT). The aim of our study is to compare the efficacy of Ca-EP with bleomycin-based ECT. This double-blinded randomized controlled phase II study was conducted at the Medical University of Szeged, Hungary. During this once only treatment up to ten measurable cutaneous metastases per patient were separately block randomized for intratumoral delivery of either calcium or bleomycin, which was followed by reversible electroporation. Tumour response was evaluated clinically and histologically six months after treatment. (ClinicalTrials.gov: NCT03628417, closed). Seven patients with 44 metastases (34 from malignant melanoma, 10 from breast cancer) were included in the study. Eleven metastases were taken for biopsies, and 33 metastases were randomised and treated once. The objective response rates were 33% (6\/18) for Ca-EP and 53% (8\/15) for bleomycin-based ECT, with 22% (4\/18) and 40% (6\/15) complete response rates, respectively. The CR was confirmed histologically in both arms. Serious adverse events were not registered. Ulceration and hyperpigmentation, both CTCA criteria grade I side effects, were observed more frequently after bleomycin-based ECT than for Ca-EP. Ca-EP was non-inferior to ECT, therefore, it should be considered as a feasible, effective and safe treatment option.<\/jats:p>","DOI":"10.3390\/cancers12010179","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T04:05:51Z","timestamp":1578888351000},"page":"179","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Evaluation of Calcium Electroporation for the Treatment of Cutaneous Metastases: A Double Blinded Randomised Controlled Phase II Trial"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4002-5507","authenticated-orcid":false,"given":"D\u00f3ra","family":"\u00c1goston","sequence":"first","affiliation":[{"name":"Department of Dermatology and Allergology, University of Szeged, 6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0357-7393","authenticated-orcid":false,"given":"Eszter","family":"Balt\u00e1s","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology, University of Szeged, 6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"\u00d3csai","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology, University of Szeged, 6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ndor","family":"R\u00e1tkai","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology, University of Szeged, 6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter Gy","family":"L\u00e1z\u00e1r","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, University of Szeged, 6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Korom","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology, University of Szeged, 6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Varga","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology, University of Szeged, 6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n Bal\u00e1zs","family":"N\u00e9meth","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology, University of Szeged, 6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"D\u00f3sa-R\u00e1cz Viharosn\u00e9","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology, University of Szeged, 6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gehl","sequence":"additional","affiliation":[{"name":"Center for Experimental Drug and Gene Electrotransfer (C*EDGE), Department of Clinical Oncology and Palliative Care, Zealand University Hospital, 4000 Roskilde, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Ol\u00e1h","sequence":"additional","affiliation":[{"name":"Department of Oncotherapy, University of Szeged, 6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2119-9501","authenticated-orcid":false,"given":"Lajos","family":"Kem\u00e9ny","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology, University of Szeged, 6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Gabriella","family":"Kis","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology, University of Szeged, 6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10549-012-2095-4","article-title":"The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: A phase-II study","volume":"134","author":"Campana","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/bjd.15340","article-title":"Electrochemotherapy in the treatment of metastatic malignant melanoma: A prospective cohort study by InspECT","volume":"176","author":"Kunte","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejcsup.2006.08.002","article-title":"Electrochemotherapy\u2014An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study","volume":"4","author":"Marty","year":"2006","journal-title":"EJC Suppl."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3109\/0284186X.2011.573626","article-title":"Management of cutaneous metastases using electrochemotherapy","volume":"50","author":"Matthiessen","year":"2011","journal-title":"Acta Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jso.23481","article-title":"Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: A series of 39 patients treated with palliative intent","volume":"109","author":"Solari","year":"2014","journal-title":"J. Surg. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1245\/s10434-011-1860-7","article-title":"Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: A two-center prospective phase II trial","volume":"19","author":"Curatolo","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.ejso.2019.07.003","article-title":"Electrochemotherapy for the palliative management of cutaneous metastases: A systematic review and meta-analysis","volume":"45","author":"Morley","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ceca.2011.03.003","article-title":"Calcium and cell death mechanisms: A perspective from the cell death community","volume":"50","author":"Zhivotovsky","year":"2011","journal-title":"Cell Calcium"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.bbagen.2013.12.003","article-title":"Calcium electroporation in three cell lines: A comparison of bleomycin and calcium, calcium compounds, and pulsing conditions","volume":"1840","author":"Frandsen","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9412","DOI":"10.1038\/s41598-018-27728-z","article-title":"Effect of calcium electroporation on tumour vasculature","volume":"8","author":"Staresinic","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/0284186X.2017.1355109","article-title":"Calcium electroporation for treatment of cutaneous metastases; a randomized double-blinded phase II study, comparing the effect of calcium electroporation with electrochemotherapy","volume":"57","author":"Falk","year":"2018","journal-title":"Acta Oncol."},{"key":"ref_12","unstructured":"(2019, November 13). Philadelphia: ECOG-Acrin Cancer Research Group. Available online: ecog-acrin.org\/resources\/ecog-performance-status."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1158\/0008-5472.CAN-16-1611","article-title":"Normal and Malignant Cells Exhibit Differential Responses to Calcium Electroporation","volume":"77","author":"Frandsen","year":"2017","journal-title":"Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1158\/0008-5472.CAN-11-3782","article-title":"Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis","volume":"72","author":"Frandsen","year":"2012","journal-title":"Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/0284186X.2014.992546","article-title":"Predicting patients at risk for pain associated with electrochemotherapy","volume":"54","author":"Quaglino","year":"2015","journal-title":"Acta Oncol."},{"key":"ref_17","unstructured":"(2019, November 13). Common Terminology Criteria for Adverse Events (CTCAE), Version 4.0, Available online: https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s11606-010-1513-8","article-title":"Understanding Equivalence and Noninferiority Testing","volume":"26","author":"Walker","year":"2011","journal-title":"J. Gen. Intern. Med."},{"key":"ref_19","unstructured":"(2019, November 13). Hong Kong: Center for Clinical Research and Biostatistics. Available online: www2.ccrb.cuhk.edu.hk\/stat\/proportion\/tspp_sup.htm."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/lio2.233","article-title":"Calcium electroporation for recurrent head and neck cancer: A clinical phase I study","volume":"4","author":"Plaschke","year":"2019","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Frandsen, S.K., and Gehl, J. (2017). Effect of calcium electroporation in combination with metformin In Vivo and correlation between viability and intracellular ATP level after calcium electroporation In Vitro. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181839"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1038\/s41598-019-41188-z","article-title":"Calcium electroporation and electrochemotherapy for cancer treatment: Importance of cell membrane composition investigated by lipidomics, calorimetry and in vitro efficacy","volume":"9","author":"Hoejholt","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Hansen, E.L., Sozer, E.B., Romeo, S., Frandsen, S.K., Vernier, P.T., and Gehl, J. (2015). Correction: Dose-dependent ATP depletion and cancer cell death following calcium electroporation, relative effect of calcium concentration and electric field strength. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128034"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Frandsen, S.K., Gibot, L., Madi, M., Gehl, J., and Rols, M.P. (2015). Calcium Electroporation: Evidence for Differential Effects in Normal and Malignant Cell Lines, Evaluated in a 3D Spheroid Model. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0144028"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00232-016-9910-5","article-title":"Difference in Membrane Repair Capacity Between Cancer Cell Lines and a Normal Cell Line","volume":"249","author":"Frandsen","year":"2016","journal-title":"J. Membr. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1533033818788072","DOI":"10.1177\/1533033818788072","article-title":"ESOPE-Equivalent Pulsing Protocols for Calcium Electroporation: An In Vitro Optimization Study on 2 Cancer Cell Models","volume":"17","author":"Romeo","year":"2018","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.18632\/oncotarget.24352","article-title":"Calcium electroporation for treatment of sarcoma in preclinical studies","volume":"9","author":"Szewczyk","year":"2018","journal-title":"Oncotarget"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1080\/0284186X.2017.1290274","article-title":"Electrochemotherapy and calcium electroporation inducing a systemic immune response with local and distant remission of tumors in a patient with malignant melanoma\u2014A case report","volume":"56","author":"Falk","year":"2017","journal-title":"Acta Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1515\/raon-2016-0042","article-title":"Electrochemotherapy with bleomycin is effective in BRAF mutated melanoma cells and interacts with BRAF inhibitors","volume":"50","author":"Dolinsek","year":"2016","journal-title":"Radiol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0304-4165(99)00094-X","article-title":"In vivo electroporation of skeletal muscle: Threshold, efficacy and relation to electric field distribution","volume":"1428","author":"Gehl","year":"1999","journal-title":"Biochim. Et Biophys. Acta"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0006-3495(98)77924-X","article-title":"The importance of electric field distribution for effective in vivo electroporation of tissues","volume":"74","author":"Miklavcic","year":"1998","journal-title":"Biophys. J."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/1\/179\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:19:29Z","timestamp":1760361569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/1\/179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,10]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["cancers12010179"],"URL":"https:\/\/doi.org\/10.3390\/cancers12010179","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,10]]}}}